Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation TCT 2025

Pearls and Pitfalls of Left Main PCI

Presenter: Duk-Woo Park

October 28, 2025

Presentation TCT 2025

Provisional Left Main Stenting: Contemporary Considerations

Presenter: Duk-Woo Park

October 28, 2025

Presentation TCT 2025

High risk / CTO PCI with use of Cangrelor

Presenter: Duk-Woo Park

October 28, 2025

Presentation TCT 2025

When to Act and When to Wait: Managing High-Risk Plaques and Patients

Presenter: Duk-Woo Park

October 27, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Presenter: Duk-Woo Park

October 26, 2025

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

Presentation TCT 2024

Pro

Presenter: Duk-Woo Park

October 28, 2024

Presentation TCT 2023

DAPT Duration: Unsettled or Case Closed?

Presenter: Duk-Woo Park

October 24, 2023

Presentation ESC 2023

Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI: The OCTIVUS Randomized Clinical Trial

Presenter: Duk-Woo Park

August 28, 2023

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation TCT 2021

Case 4: OCT vs IVUS-Guided Management of Coronary Calcification – Direct Comparison

Presenter: Duk-Woo Park

November 06, 2021

Presentation TCT 2019

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Presenter: Duk-Woo Park

September 28, 2019

Presentation TCT 2018

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Duk-Woo Park

September 23, 2018

Presentation TCT 2018

Long-Term Outcomes of LM PCI vs CABG: New Insights From the MAIN-COMPARE and IRIS-MAIN Registries

Presenter: Raj Makkar, Patrick W. Serruys, Duk-Woo Park

September 23, 2018

Presentation TCTAP 2018

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Presenter: Duk-Woo Park

April 28, 2018

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE II: IRIS-MAIN

Presenter: Antonio Colombo, David E. Kandzari, Duk-Woo Park

October 31, 2017

Presentation TCT 2017

Severe Calcified Coronary Lesions: The Next Target

Presenter: Gary S. Mintz, Seung-Jung Park, Duk-Woo Park

October 29, 2017

Presentation TCT 2017

How to Optimize Left Main and Bifurcation PCI: Secular Trends

Presenter: Gary S. Mintz, Seung-Jung Park, Duk-Woo Park

October 29, 2017

Presentation TCT 2017

Flash Debate #1: For Left Main Distal Bifurcation Disease the Provisional Approach Is Preferred!

Presenter: Fazila T. Malik, Jack Wei Chieh Tan, Duk-Woo Park

October 29, 2017

Presentation TCT 2016

What Really Matters in Bifurcation PCI? Technique or Concept

Presenter: Seung-Jung Park, Alan C. Yeung, Duk-Woo Park

October 31, 2016

Advertisement

Pearls and Pitfalls of Left Main PCI

Provisional Left Main Stenting: Contemporary Considerations

High risk / CTO PCI with use of Cangrelor

When to Act and When to Wait: Managing High-Risk Plaques and Patients

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Pro

DAPT Duration: Unsettled or Case Closed?

Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI: The OCTIVUS Randomized Clinical Trial

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Case 4: OCT vs IVUS-Guided Management of Coronary Calcification – Direct Comparison

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Long-Term Outcomes of LM PCI vs CABG: New Insights From the MAIN-COMPARE and IRIS-MAIN Registries

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Exploring Diversity and Generalizability of EXCEL/NOBLE II: IRIS-MAIN

Severe Calcified Coronary Lesions: The Next Target

How to Optimize Left Main and Bifurcation PCI: Secular Trends

Flash Debate #1: For Left Main Distal Bifurcation Disease the Provisional Approach Is Preferred!

What Really Matters in Bifurcation PCI? Technique or Concept

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content